Once-daily trospium chloride 60 mg extended-release provides effective, long-term relief of overactive bladder syndrome symptoms.

about

Once-daily trospium chloride 60 mg extended-release provides effective, long-term relief of overactive bladder syndrome symptoms.

Item

http://www.wikidata.org/entity/Q39268095

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Once-daily trospium chloride 6 ...... ive bladder syndrome symptoms.

@en

Once-daily trospium chloride 6 ...... ive bladder syndrome symptoms.

@nl

type

Item

label

Once-daily trospium chloride 6 ...... ive bladder syndrome symptoms.

@en

Once-daily trospium chloride 6 ...... ive bladder syndrome symptoms.

@nl

prefLabel

Once-daily trospium chloride 6 ...... ive bladder syndrome symptoms.

@en

Once-daily trospium chloride 6 ...... ive bladder syndrome symptoms.

@nl

P1476

Once-daily trospium chloride 6 ...... tive bladder syndrome symptoms

@en

P2093

David R Staskin

http://www.w3.org/2001/XMLSchema#string

Michael G Oefelein

http://www.w3.org/2001/XMLSchema#string

Norman R Zinner

http://www.w3.org/2001/XMLSchema#string

Peter K Sand

http://www.w3.org/2001/XMLSchema#string

Roger R Dmochowski

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical pharmacokinetics of trospium chloride

Muscarinic receptor antagonists in the treatment of overactive bladder.

The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society.

Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence.

Long-term open-label solifenacin treatment associated with persistence with therapy in patients with overactive bladder syndrome.

Long-term benefits of darifenacin treatment for patient quality of life: results from a 2-year extension study.

The overactive bladder-symptom composite score: a composite symptom score of toilet voids, urgency severity and urge urinary incontinence in patients with overactive bladder.

A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials.

Trospium 60 mg once daily (QD) for overactive bladder syndrome: results from a placebo-controlled interventional study.

Baseline incontinence severity is predictive of the percentage of patients continent after receiving once-daily trospium chloride extended release.

P304

1214-1219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/NAU.21000

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paul Siami

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21462240

http://www.w3.org/2001/XMLSchema#string